63 results
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
7:35am
and Administrative Expense2 30.2 17.1 56.8 35.1 Total Cost and Operating Expenses 123.0 49.3 189.8 95.1 Other Income3 111.9 3.4 116.3 6.8 Income Tax Expense 1.5
8-K
EX-99.3
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
7:35am
and Administrative Expense2 30.2 17.1 56.8 35.1 Total Cost and Operating Expenses 123.0 49.3 189.8 95.1 Other Income3 111.9 3.4 116.3 6.8 Income Tax
8-K
EX-99.1
9hmjir dq
30 Jul 24
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
7:35am
8-K
EX-10.1
h77d5
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
8-K
EX-4.1
ggo5foru3kir5w1g
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
S-8
EX-99.2
geyqe523ceo12 rq
4 Jan 24
Registration of securities for employees
4:06pm
S-8
EX-99.1
kevyd1i7t6a4cp6
4 Jan 24
Registration of securities for employees
4:06pm
S-3ASR
EX-4.4
rnxow1u
14 Sep 23
Automatic shelf registration
5:28pm
S-3ASR
e182bhm
14 Sep 23
Automatic shelf registration
5:28pm
S-3ASR
EX-4.3
zeh 74qam
14 Sep 23
Automatic shelf registration
5:28pm
8-K
EX-1.1
dc0 p30ahc2mv
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm